Xueshuantong injection (lyophilized) combined with salvianolate lyophilized injection protects against focal cerebral ischemia/reperfusion injury in rats through attenuation of oxidative stress

• 来源期刊: 中国药理学报（英文版）
• 关键词: stroke cerebral ischemia-reperfusion injury oxidative stress Nrf-2/Keap1 pathway Salvianolate lyophilized injection Xueshuantong injection (lyophilized) edaravone
• 年，卷（期）: 2018,（6）
• 页码范围: 998-1011
• 页数: 14页
• 语种: 英文
• DOI: 10.1038/aps.2017.128

摘要

Salvianolate lyophilized injection (SLI) and Xueshuantong injection (lyophilized) (XST) are two herbal standardized preparations that have been widely used in China for the treatment of acute cerebral infarction. In this study, we investigated the neuroprotective effects of SI combined with XST in a rat model of middle cerebral artery occlusion-reperfusion (MCAO/R). Wistar rats were subjected to 1.5 h of MCAO followed by reperfusion for 3 h, then were treated with SLI or XST alone, or with their combinations via tail vein injection daily for 3 d. Edaravone (EDI, 6 mg-kg-1d-1) was used as a positive control drug, We showed that administration of a combination of 1×1S (XST 100 mg-kg1d1 plus SLI 21 mg.kg11-d1) more effectively protected the ischemic brains than SLI or XST used alone. Administration of 1×1S not only significantly decreased neurological deficit scores and infarct volumes and increased regional cerebral blood flow, but also inhibited the activation of both microglia and astrocytes in the hippocampus. Furthermore, administration of 1×1S significantly decreased the levels of MDA and ROS with concomitant increases in the levels of antioxidant activity (SOD, CAT and GSH) in the brain tissues as compared with SLI and XST used alone. Moreover, administration of 1×1S remarkably upregulated the expression of Nrf-2, HO-1 and NQO-1, and downregulated the expression of Keap1 and facilitated the nuclear translocation of Nrf-2 in the brain tissues as compared with XST used alone. Our study demonstrates that a combination of 1x1S effectively protects MCAO/R injury via suppressing oxidative stress and the Nrf-2/Keap1 pathway.